How much funding has Orasis Pharmaceuticals raised?

Orasis Pharmaceuticals has raised $121.0M in total funding, most recently a Growth Equity round.

Who are Orasis Pharmaceuticals's investors?

Orasis Pharmaceuticals's investors include Visionary Ventures, Sequoia Capital, SBI Investment.

When was Orasis Pharmaceuticals founded?

Orasis Pharmaceuticals was founded in 2015.

Where is Orasis Pharmaceuticals headquartered?

Orasis Pharmaceuticals is headquartered in Tel Aviv, Israel.

What industry is Orasis Pharmaceuticals in?

Orasis Pharmaceuticals operates in Healthcare, Medical.

How many employees does Orasis Pharmaceuticals have?

Orasis Pharmaceuticals has 11-50 employees.

Orasis Pharmaceuticals

Reshaping Vision Possibilities

Tel Aviv, Israel · Founded 2015 · $121.0M raised

Healthcare

Medical

Headquarters: Tel Aviv
Employees: 11–50
Founded: 2015
Business Model: B2B

Website: orasis-pharma.com
Total Funding: $121.0M
Last Round: $78.0M Growth EquityOct 2024
Rounds: 3

About

Orasis Pharmaceuticals is an ophthalmic pharmaceutical company focused on near vision correction. They developed Qlosi (pilocarpine hydrochloride 0.4%), a preservative-free prescription eye drop FDA-approved in 2023 for the treatment of presbyopia in adults. The company targets the nearly 128 million Americans living with age-related blurry near vision as an alternative to reading glasses or surgery.

Summary

Orasis Pharmaceuticals is a Healthcare company based in Tel Aviv, Israel, founded in 2015. It has raised $121.0M in total across 3 rounds, most recently a $78.0M Growth Equity round in Oct 2024. Investors include Visionary Ventures, Sequoia Capital and SBI Investment.

LinkedIn X (Twitter)